INOVIO PHARMACEUTICALS, INC. Deferred Income Tax Liabilities, Net
INOVIO PHARMACEUTICALS, INC. (INO) had Deferred Income Tax Liabilities, Net of $0 as of 2023-12-31, per its 10-K filed 2024-03-06.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredIncomeTaxLiabilitiesNet · last filed 2024-03-06
- 2023-12-31: Deferred Income Tax Liabilities, Net $0.00.
- 2023-09-30: Deferred Income Tax Liabilities, Net $32.05K.
- 2023-06-30: Deferred Income Tax Liabilities, Net $32.05K.
- 2023-03-31: Deferred Income Tax Liabilities, Net $32.05K.
| Period end | Deferred Income Tax Liabilities, Net |
|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-03-06 |
| 2023-09-30 | $32.05K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $32.05K 10-Q · filed 2023-08-09 |
| 2023-03-31 | $32.05K 10-Q · filed 2023-05-10 |
| 2022-12-31 | $32.05K 10-K · filed 2024-03-06 |
| 2022-09-30 | $32.05K 10-Q · filed 2022-11-08 |
| 2022-06-30 | $32.05K 10-Q · filed 2022-08-09 |
| 2022-03-31 | $32.05K 10-Q · filed 2022-05-10 |
| 2021-12-31 | $32.05K 10-K · filed 2023-03-01 |
| 2021-09-30 | $32.05K 10-Q · filed 2021-11-09 |
| 2021-06-30 | $32.05K 10-Q · filed 2021-08-09 |
| 2021-03-31 | $32.05K 10-Q · filed 2021-05-10 |
| 2020-12-31 | $32.05K 10-K · filed 2022-03-01 |
| 2020-09-30 | $32.05K 10-Q · filed 2020-11-09 |
| 2020-06-30 | $32.05K 10-Q · filed 2020-08-10 |
| 2020-03-31 | $32.05K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $32.05K 10-K · filed 2021-03-01 |
| 2019-09-30 | $26.65K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $26.65K 10-Q · filed 2019-08-08 |
| 2019-03-31 | $24.77K 10-Q · filed 2019-05-09 |
| 2018-12-31 | $24.77K 10-K · filed 2020-03-12 |
| 2018-09-30 | $24.77K 10-Q · filed 2018-11-08 |
| 2018-06-30 | $24.77K 10-Q · filed 2018-08-07 |
| 2018-03-31 | $24.77K 10-Q · filed 2018-05-09 |
| 2017-12-31 | $24.77K 10-K · filed 2019-03-12 |
| 2017-09-30 | $174.79K 10-Q · filed 2017-11-08 |
| 2016-12-31 | $174.79K 10-K · filed 2018-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |